© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 8, 597A-597,
April 19, 2000
© 2000 Oxford University Press
NEWS |
Correction
In a story in the Feb. 2 News ("Gene Patent Race Speeds Ahead Amid Controversy, Concern," p. 184), a quotation was misattributed. The paragraph should read:"Some people will feel that this is still not satisfactory public policy," Hanson (James Hanson, M.D., acting chief of the National Cancer Institutes Clinical and Genetic Epidemiology Research Branch) acknowledged, "but it was the best we could do at this time," given Myriads intellectual property rights to the gene.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||